Agios Pharmaceuticals Inc Működési árrés
Mi az Agios Pharmaceuticals Inc Működési árrés?
A Működési árrés az Agios Pharmaceuticals Inc - -1,293.88%
Mi a Működési árrés meghatározása?
A működési árrés a működési bevételek aránya a nettó árbevétel és százalékban kifejezve.
Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.
Működési árrés a Health Care szektor a NASDAQ-on cégekben a Agios Pharmaceuticals Inc -hoz képest
Mit csinál Agios Pharmaceuticals Inc?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
működési árrés -hoz hasonló cégek Agios Pharmaceuticals Inc
- Vuzix nak Működési árrés -1,303.24% van
- First Foods nak Működési árrés -1,301.23% van
- Synstream nak Működési árrés -1,299.86% van
- Nikola nak Működési árrés -1,296.88% van
- Generation Bio Co nak Működési árrés -1,295.89% van
- Wattle Health Australia nak Működési árrés -1,294.26% van
- Agios Pharmaceuticals Inc nak Működési árrés -1,293.88% van
- Solei Systems nak Működési árrés -1,293.76% van
- AppsVillage Australia nak Működési árrés -1,291.87% van
- Premier nak Működési árrés -1,283.25% van
- MIC Electronics nak Működési árrés -1,276.88% van
- The Hempshire Inc nak Működési árrés -1,276.47% van
- National Investments Fund nak Működési árrés -1,272.90% van